EUCTR2013-002553-29-DK进行中（未招募）不适用
Metabolic changes due to iatrogenic hypogonadism in patients with prostate cancer: orchiectomy vs. triptorelin
Jens Sønksen0 个研究点开始时间: 2013年7月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •1. diagnosed prostate cancer, where life long ADT is indicated.
- •2. Age 18 - 90 years
- •3. ECOG performance status 0-2
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 38
排除标准
- •1. Previous androgen deprivation therapy.
- •2. Anti-androgen treatment befor start of ADT, antiflare treatment after randomisation is accepted.
- •3. Hemophelia or other condition that increases the risk of complications for orchiectomy unreasonably.
- •4. Prior treatment for osteoporosis.
- •5. Known diabetes and/or HbA1C > 6,5
研究者
相似试验
尚未招募
不适用
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenHypogonadism, MaleTestosterone DeficiencyAndrogen DeficiencyMetabolic DiseaseMetabolic SyndromeMetabolic DisturbanceCardiovascular DiseasesNAFLDObesityProstate CancerDiabetesNCT05773183Royal College of Surgeons, Ireland60
已完成
4 期
A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone InjectionsHypogonadism, MaleNCT04439799University of Miami81
已完成
4 期
MRI Substudy; Metabolic Changes Due to Iatrogenic HypogonadismMetabolic SyndromeHypogonadismProstate CancerFatty LiverNCT02102646Herlev Hospital31
Unknown
不适用
Metabolic Profile and Adipokine Levels in Young Hyperandrogenemic FemalesHyperandrogenismMetabolic DiseaseMetabolic SyndromeObesityNCT05112029Medical University of Gdansk40
进行中（未招募）
不适用
Effects on Endocrine-Metabolic Parameters and Body Composition of the Addition of Low-Dose Pioglitazone to Flutamide-Metformin Therapy in Young Women with Hyperinsulinemic Ovarian Hyperandrogenism and Cardiovascular Risk - Pioglitazone in PCOSPolycystic Ovary Syndrome includes anovulatory hyperandrogenism, hyperinsulinemia and/or dyslipidemia. Adiponectin and interleukin-6 are adipocytokines that have been related to abdominal fat excess and/or impaired insulin sensitivity. These cytokines -together with other indices of low-grade inflammation-, sucj as C-reactive protein (CRP), and the neutrophil count, contribute to link insulin-resistant states with cardiovascular disease risks.EUCTR2005-004163-39-ESHospital Sant Joan de Déu40